According to Biofrontera's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.42. At the end of 2024 the company had a P/S ratio of 0.2007.
Year | P/S ratio | Change |
---|---|---|
2024 | 0.2007 | 62.65% |
2023 | 0.1234 | -85.54% |
2022 | 0.8535 | -81.83% |
2021 | 4.70 |